Sumitomo Pharma shares plunge 12% despite greenlight for Parkinson's treatment ⊕
found
You are not logged in so some information on this page has been withheld. To see more, please log in or sign up.
Pharma
since
auto-detected in 25 stories
8 days ago
Shares of Japan's Sumitomo Pharma fell over 12% on the back of profit-taking after a specialist panel endorsed its iPS cell-based therapy for Parkinson's disease.
86 days ago
Pharma lobbyists to EU: Cut deals with Trump ○
Advocates for European drugmakers say other countries must follow the UK to the bargaining table to stave off tariffs and remain competitive.
87 days ago
Pharma lobbyists to EU: Cut deals with Trump ○
Advocates for European drugmakers say other countries must follow the UK to the bargaining table to stave off tariffs and remain competitive.
3 months ago
Why Medicare price negotiations matter for Novo Nordisk, AstraZeneca, and other European pharma companies ⊖
found
Pharma companies are facing pricing pressure from several directions, including from the U.S. Medicare negotiations
Pharma sounds alarm over EU plans to procure novel medicines ⊖
Both the branded and generic drug sectors argue joint procurement can't solve all shortages problems.
Eli Lilly and Merck’s blockbuster drug sales power earnings ⊕⊕
found
a story from Financial Times ✅ › Financial Times
Pharma groups boost financial outlooks as revenues from flagship medicines like Zepbound and Keytruda leap
4 months ago
Pharma shake-up: Surprise change of CEO at GSK, as AstraZeneca announces New York stock market listing – business live ○
Rolling coverage of the latest economic and financial news, as GSK has appointed a new boss after announcing the departure of Dame Emma Walmsley.
GSK’s Emma Walmsley to be replaced as chief executive
I…
5 months ago
Pharma lobby blasts Oct. 1 Trump tariff threat ○
The European Commission says EU industry should be protected from the latest tariff threat through the EU-U.S. trade deal.
Pharma firms pile pressure on the UK as Trump's drug pricing order looms ○
A number of global pharma firms have pulled or paused U.K. investment plans amid waning government support and drug pricing talks.
6 months ago
Rocket Pharma's shares soar after US FDA lets gene therapy trial resume ○
The drugmaker's shares were up 19% in midday trading after soaring more than 30% earlier Wednesday morning.